UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034530
Receipt number R000039326
Scientific Title A Prospective Longitudinal Observational Study of Clinical Outcomes, Adverse Events, and Secondary Malignancies After Definitive Radiotherapy for Breast Cancer Patients
Date of disclosure of the study information 2018/10/27
Last modified on 2020/01/28 16:05:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Prospective Longitudinal Observational Study of Clinical Outcomes, Adverse Events, and Secondary Malignancies After Definitive Radiotherapy for Breast Cancer Patients

Acronym

Longitudinal Observational Study after Definitive Radiotherapy for Breast Cancer (TOKYO Database)

Scientific Title

A Prospective Longitudinal Observational Study of Clinical Outcomes, Adverse Events, and Secondary Malignancies After Definitive Radiotherapy for Breast Cancer Patients

Scientific Title:Acronym

Longitudinal Observational Study after Definitive Radiotherapy for Breast Cancer (TOKYO Database)

Region

Japan


Condition

Condition

Breast Cancer

Classification by specialty

Hematology and clinical oncology Breast surgery Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Rigorous long-term observation is critical in elucidating real-world clinical outcomes, adverse events, and secondary malignancies in patients with breast cancer who underwent definitive radiotherapy. This is a multicenter prospective observational study in center of Tokyo. The aim of our study is to investigate long-term outcomes including survival, recurrence, and any other relevant clinical data.

Basic objectives2

Others

Basic objectives -Others

Detailed super-long-term (life-long) observational study

Trial characteristics_1

Others

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Survival data (Breast cancer specific death/Death from any cause)
Recurrence data (Loco-regional relapse/Distant metastasis)

Key secondary outcomes

Contralateral breast cancer (Synchronous/Metachronous breast cancer)
Secondary malignancies (non-breast malignant disease)
Adverse events (treatment-related/non-treatment-related)
Any other clinically meaningful events


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

All patients with invasive carcinoma/ductal carcinoma in situ/lobular carcinoma in situ of the breast whose primary therapy includes definitive radiation therapy in participating institutions

Key exclusion criteria

Patients with metastasis at diagnosis

Target sample size

4000


Research contact person

Name of lead principal investigator

1st name Kenshiro
Middle name
Last name Shiraishi

Organization

The University of Tokyo Hospital

Division name

Department of Radiology

Zip code

113-8655

Address

7-3-1, Hongo, Bunkyo-ku, Tokyo

TEL

03-3815-5411

Email

kshiraishi-tky@umin.ac.jp


Public contact

Name of contact person

1st name Kenshiro
Middle name
Last name Shiraishi

Organization

The University of Tokyo Hospital

Division name

Department of Radiology

Zip code

113-8655

Address

7-3-1, Hongo, Bunkyo-ku, Tokyo

TEL

03-3815-5411

Homepage URL


Email

kshiraishi-tky@umin.ac.jp


Sponsor or person

Institute

The University of Tokyo

Institute

Department

Personal name



Funding Source

Organization

Teikyo University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

MITSUI Memorial Hospital
RIKEN (Medical Sciences Innovation Hub Program)
Tokyo University of Science

Name of secondary funder(s)

St. Luke's International University
Public Interest Foundation Japan Cancer Society


IRB Contact (For public release)

Organization

Research Ethics Committee at The University of Tokyo

Address

7-3-1, Hongo, Bunkyo-ku

Tel

03-5841-0818

Email

ethics@m.u-tokyo.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

MEC2017 3B-C65

Org. issuing International ID_1

MITSUI Memorial Hospital

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 10 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

4000

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

1978 Year 12 Month 02 Day

Date of IRB

2011 Year 04 Month 26 Day

Anticipated trial start date

1978 Year 12 Month 02 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Life-long observational study based on real-world cohort of all patients whose primary therapy includes definitive radiation therapy in participating institutions

TOKYO Database:
TOkyo daigaku (the university of tokyo) and mitsui Kinen (memorial) bYOin (hospital)

This big data is expected to provide real-world outcome-based evidence that is novel and useful in shared decision making and updating clinical practice guideline


Management information

Registered date

2018 Year 10 Month 16 Day

Last modified on

2020 Year 01 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039326


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name